Navigation Links
Nicotinic Acid: The Key Ingredient in Niacin Dietary Supplements that Supports Heart Health

MAPLE GROVE, Minn., Dec. 8, 2011 /PRNewswire/ -- Among the forms of dietary supplement niacin, including "flush-free" niacin, only nicotinic acid, the key ingredient in Slo-Niacin®, is clinically proven to support good cholesterol (HDL). Slo-Niacin® helps maintain good cholesterol within the healthy range.  Many of those "flush-free" and "laboratory tested" niacin supplements calling out to you from the nutrition aisle contain niacin in the form of inositol hexaniacinate, inositol hexanicotinate or nicotinamide. These types of niacin are not intended for the heart health-minded supplement seeker who wants a form that is clinically proven to support good cholesterol (HDL).

"Perusing the dietary supplements aisle can be overwhelming, so when I recommend a niacin supplement to my patients to help support their heart health, my guidance is quite simple--if it doesn't include nicotinic acid, leave the bottle on the shelf and find one that does," said Dr. Carl Lavie, medical director of Cardiac Rehabilitation and Prevention, John Ochsner Heart and Vascular Institute, New Orleans, LA. "I recommend Slo-Niacin® to my patients because it includes nicotinic acid, the only form of dietary supplement niacin that is clinically proven to support good cholesterol, also known as HDL. It works, and its unique formulation helps to minimize flushing, a harmless side effect that sometimes occurs with niacin use."

About Niacin and Good Cholesterol (HDL)

Niacin is a type of B vitamin that occurs naturally and aids in the function of the digestive system, skin, and nervous system and can help maintain good cholesterol (HDL) within the normal range. Niacin, or nicotinic acid, has been used since the 1950s to support healthy good cholesterol. Niacin in the form of nicotinic acid is clinically proven to support good cholesterol (HDL). High-density lipoprotein (HDL) cholesterol is known as good cholesterol because it is thought to help move cholesterol out of the arteries and into the liver so the body can get rid of it. A normal level of HDL cholesterol in your blood is higher than 40 mg/dL.  

About Slo-Niacin® Tablets

Slo-Niacin® Tablets utilize a unique polygel® controlled-release system, not available in other dietary supplement niacin products, that gradually delivers nicotinic acid into the body and is designed to reduce the likelihood of flushing commonly associated with immediate-release niacin use. At approximately $16 for one-hundred 500 mg tablets, Slo-Niacin® Tablets are an affordable option to help support a healthy heart. To support individual heart health needs, Slo-Niacin® Tablets are available in three strengths (250 mg, 500 mg, and 750 mg).

Slo-Niacin® Tablets are manufactured by Upsher-Smith Laboratories, Inc., a trusted manufacturer of high-quality dietary supplement and prescription products since 1919. Over the last 20 years, more than 12 million bottles have been sold.  Slo-Niacin® Tablets are conveniently available at pharmacies and other retailers nationwide, without a prescription. For more information, coupons, and a store locator, visit

About Upsher-Smith Laboratories, Inc.

Upsher-Smith Laboratories, Inc. is a rapidly growing pharmaceutical company that manufactures and markets both consumer and prescription products. Privately held since 1919, the company strives to recognize the unmet healthcare needs of our customers. Upsher-Smith prides itself in providing safe, effective, and economical therapies to the ever-changing healthcare environment. For additional information about Upsher-Smith, visit

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Dr. Lavie consults on behalf of Upsher-Smith Laboratories, Inc.

Data on File. Upsher-Smith Laboratories, Inc.; 2011.
Slo-Niacin product information. Upsher-Smith
            Laboratories, 2011. Accessed Oct. 11, 2011.  
Mayo Clinic Web site. Accessed Oct. 11, 2011.
NHLBI: National Cholesterol Education Program. Accessed Oct. 11, 2011.
Harvard Health Lett. 2007;July:7. Accessed April 11, 2011.
American Heart Association Web site. Accessed Nov. 9, 2011.


SOURCE Upsher-Smith Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. EnVivo Pharmaceuticals Announces Initiation of Clinical Safety and Biomarker Study of Alpha-7 Nicotinic Agonist, EVP-6124, in Patients with Schizophrenia
2. Roche Exercises its Option to Further Develop and Commercialize Memory Pharmaceuticals Nicotinic Alpha-7 Agonist, MEM 3454
3. Asmacure Ltee Issued Patent to Govern Composition-of-Matter for its Nicotinic Receptor Technology in the U.S.
4. Tainted Chinese Food Ingredients First Discovered in 2005
5. ChemImages Raman Chemical Imaging Used for Ingredient-Specific Particle Sizing for Inhalation Product Development
6. Make Meth Ingredients Prescription-Only Says Former White House Drug Spokesman Bob Weiner; Oregon Did and Cut Crisis by Half
7. FDA Orders Halt to Marketing of Unapproved Single-Ingredient Oral Colchicine
8. Reportlinker Adds Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth
9. B. Braun Voluntarily Recalls Seven Lots of Heparin Manufactured in 2008 Due to Supplier-Initiated Recall of Heparin Active Pharmaceutical Ingredient (API)
10. Baxa Corporation Introduces ExactaMix™ 1200 Automated Compounder for Sterile, Multi-Ingredient Solutions
11. Health on the Agenda at Food ingredients Asia-China Trade Show
Post Your Comments:
(Date:12/1/2015)... N.J. , Dec. 1, 2015 ... held in San Francisco, CA ... solutions to the coronary marketplace. During a satellite ... in Stent Design to Minimize Restenosis", a renowned ... currently available Medinol NIRxcell™ CoCr Coronary Stent System ...
(Date:12/1/2015)... 2015 Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage ... announced today that the company will present at the LD ... at the Luxe Sunset Boulevard Hotel in Los ... Relmada Therapeutics, will present on Thursday, December 3, at 9:00 ... . Please register at least 10 minutes prior to the ...
(Date:12/1/2015)...  InCarda Therapeutics, Inc. (InCarda), a privately-held biopharmaceutical company ... cardiovascular conditions via the inhalation route, today announced that ... Australia . InCarda is planning to undertake its ... in the first half of 2016. The company ... Adelaide and Melbourne.  In addition, ...
Breaking Medicine Technology:
(Date:12/1/2015)... D.C. (PRWEB) , ... December 01, 2015 , ... ... updated, comprehensive website detailing the important role that meat and poultry play ... in meat and poultry, a nutrition quiz where visitors can check their “meat ...
(Date:12/1/2015)... ... December 01, 2015 , ... Integrated Rental Services (“Integrated ... Industries International, LLC (“JII”). , With support from JII, Integrated Rental is poised ... hospitals, surgery centers, clinics, research labs and medical facilities across the United States. ...
(Date:12/1/2015)... ... 01, 2015 , ... Califia Farms , one of the fastest growing ... won top honors in Beverage World Magazine’s Global Packaging Design Awards, taking home the ... been selected as a 2015 U.S.A. Taste Champion in the American Masters of Taste ...
(Date:12/1/2015)... ... December 01, 2015 , ... December ... seen vast improvements in scientific research and discoveries, leading us to better understand ... and relief to those affected by HIV/AIDS. Mediaplanet’s cross-platform edition of “World AIDS ...
(Date:12/1/2015)... ... December 01, 2015 , ... The importance of ... is the focus of numerous abstracts accepted for presentation here, at the 101st ... Nine abstracts highlight the use of Volpara Solutions’ quantitative breast imaging software tools ...
Breaking Medicine News(10 mins):